The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

Pharmaceuticals that mimic hormones now provide effective medical tools to combat obesity. Their long-term effects on society remain to be seen.

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

Novo Nordisk lost billions in value because it failed to anticipate the risk posed by the introduction of its blockbuster ...

From surgery to supplements, GLP-1 medications are radically evolving the beauty space. We unpack the latest innovations.

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

The Delhi High Court on Tuesday dismissed Novo Nordisk's application to restrain Dr. Reddy's Laboratories Limited and ...

A pill version of Novo Nordisk A/S’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of high-risk ...

The results from the two trials of early-stage patients, called EVOKE and EVOKE+, are another setback for the Danish drugmaker and new CEO Mike Doustdar, which had seen booming success, driven by ...

Shares in Novo Nordisk, the Danish firm best known for its Wegovy and Ozempic weight loss drugs, have plunged after it called ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

Novo Nordisk shares fell sharply after the Danish drugmaker said a pill with semaglutide, the key ingredient in its Ozempic and Wegovy blockbuster drugs for obesity and diabetes, didn't slow Alzheimer ...